ToConceive is the first OTC therapy that can treat a number of infertility issues, including many male subfertility issues. Many couples incorrectly assume that it is the female’s issue that is leading to their inability to get pregnant. However, nearly half of all infertility comes from the man. Depending on what study you look at, male fertility issues account for anywhere from 30 to 60 percent of all couples’ infertility problems.
Azoospermia, the complete absence of sperm, is typically untreatable, but also extremely rare. Fortunately, most male infertility issues are treatable with the Assisted Reproductive Technologies (ART) of IntraUterine Insemination (IUI) and In Vitro Fertilization (IVF).
To treat male infertility, IUI and IVF both use laboratory in-vivo sperm washing, sperm swim-up and sperm capacitation to choose only the perfect, motile and capacitated sperm needed to achieve pregnancy. Unfortunately, IUI and IVF are invasive, expensive and not an option for many couples.
Like IUI and IVF, ToConceive mimics in-vivo sperm capacitation and accomplishes the same exact sperm selection functions to produce perfect, motile and capacitated sperm. However, ToConceive is inexpensive, easy to use and available over-the-counter.
As Dr. Thompson explains, in-vivo sperm capacitation works to allow only the fittest sperm to fertilize the egg, but can only do so with normal vaginal conception lubrication. When a woman uses ToConceive, it helps her produce and increase her own natural conception lubrication, which in turns capacitates the sperm, allowing it to travel the six or seven inches up the fallopian tube to penetrate and fertilize the egg. This in-vivo sperm capacitation also selects out immature and abnormal sperm and washes sperm coated with anti-sperm antibodies, according to Dr. Thompson.
Currently, ToConceive comes in one and three-month supplies and is available online through the Key to Conceive website (www.keytoconceive.com), as well as through Amazon, Drugstore.com and the Kindara app.